• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Lew Chern Yong

    3/18/26 4:16:22 PM ET
    $EUDA
    Medical/Nursing Services
    Health Care
    Get the next $EUDA alert in real time by email
    SEC FORM 3SEC Form 3
    FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0104
    Estimated average burden
    hours per response:0.5
    1. Name and Address of Reporting Person*
    Lew Chern Yong

    (Last)(First)(Middle)
    60 KAKI BUKIT PLACE, #03-01

    (Street)
    EUNOS TECHPARK415979

    (City)(State)(Zip)

    SINGAPORE

    (Country)
    2. Date of Event Requiring Statement (Month/Day/Year)
    03/18/2026
    3. Issuer Name and Ticker or Trading Symbol
    EUDA Health Holdings Ltd [ EUDA ]
    3a. Foreign Trading Symbol
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)Other (specify below)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Chern Yong Lew03/18/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 3: SEC 1473 (03-26)
    Get the next $EUDA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EUDA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $EUDA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant

    SINGAPORE, March 04, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ:EUDA) ("EUDA" or the "Company"), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has repurchased and cancelled in full the warrant previously issued to Streeterville Capital, LLC. Background of the Warrant As previously disclosed, the Company entered into a securities purchase agreement dated November 26, 2025 with an accredited investor for the purchase of a warrant that was immediately exercisable into up to 2,000,000 newly issued ordinary shares of the Company. The warrant was previously amended on December 16, 2025 and Januar

    3/4/26 9:10:00 AM ET
    $EUDA
    Medical/Nursing Services
    Health Care

    EUDA Health Announces Second Amendment to Streeterville Warrant Agreement

    SINGAPORE, Jan. 15, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ:EUDA) ("EUDA" or the "Company"), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has entered into a second amendment to its previously disclosed warrant agreement with Streeterville Capital, LLC. Summary of Second Warrant Amendment Terms Under the terms of the Second Warrant Amendment dated January 13, 2026, the Company and Streeterville Capital agreed to further reduce the exercise price of the warrant from US$4.00 per share to US$2.00 per share. In addition, the minimum closing price of the Company's ordinary shares required to t

    1/15/26 8:59:23 AM ET
    $EUDA
    Medical/Nursing Services
    Health Care

    EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform

    SINGAPORE, Jan. 13, 2026 (GLOBE NEWSWIRE) --  EUDA Health Holdings Limited (NASDAQ:EUDA) ("EUDA" or the "Company"), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that its wholly owned subsidiary, EUDA Health Pte. Ltd. ("EUDA Health"), has entered into a convertible loan agreement with Shenzhen Inno Immune Co., Ltd. ("Shenzhen Inno"), a developer of autologous cellular therapeutics and customised medicines for a wide range of diseases in China. Strategic Investment and Facility Expansion Plan Under the terms of the agreement, EUDA expects to invest up to RMB 6 million in two tranches, consisting of an initial tranche o

    1/13/26 7:49:00 AM ET
    $EUDA
    Medical/Nursing Services
    Health Care

    $EUDA
    SEC Filings

    View All

    SEC Form 6-K filed by EUDA Health Holdings Limited

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    3/5/26 4:30:37 PM ET
    $EUDA
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by EUDA Health Holdings Limited

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    3/2/26 8:30:27 AM ET
    $EUDA
    Medical/Nursing Services
    Health Care

    SEC Form 424B5 filed by EUDA Health Holdings Limited

    424B5 - EUDA Health Holdings Ltd (0001847846) (Filer)

    3/2/26 8:01:26 AM ET
    $EUDA
    Medical/Nursing Services
    Health Care

    $EUDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Tay Whye Shin

    3 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    3/18/26 4:17:02 PM ET
    $EUDA
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Liew Kwong Yeow

    3 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    3/18/26 4:16:39 PM ET
    $EUDA
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Lew Chern Yong

    3 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    3/18/26 4:16:22 PM ET
    $EUDA
    Medical/Nursing Services
    Health Care

    $EUDA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by EUDA Health Holdings Limited

    SC 13G - EUDA Health Holdings Ltd (0001847846) (Subject)

    3/27/24 7:35:31 AM ET
    $EUDA
    Medical/Nursing Services
    Health Care